[PDF] Top 20 Oral progestagens before menopause and breast cancer risk.
Has 10000 "Oral progestagens before menopause and breast cancer risk." found on our website. Below are the top 20 most common "Oral progestagens before menopause and breast cancer risk.".
Oral progestagens before menopause and breast cancer risk.
... progestagen-only before menopause (except for mini-pills) after the age of 40 and invasive breast cancer risk in 73 664 women from the French E3N cohort study (mean age at start ... Voir le document complet
8
Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France
... on breast cancer in France that included 739 cases and 815 population controls in postmenopausal ...40 and 50 as well as weight one year before diagnosis were obtained during in-person ... Voir le document complet
9
Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?
... : breast neoplasms, menopause, reproductive factors, risk ...on risk factors stratified by age at diagnosis or menopausal status were reviewed to better understand the role of hormonal factors ... Voir le document complet
8
Study on the associations between physical activity, inflammatory markers and two breast cancer risk factors
... cycle, before menarche, the breast is mainly formed of undifferentiated type 1 lobules, containing <12 ...the breast and evolves into type 2 lobules, containing higher number of acini ... Voir le document complet
272
Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
... ER and PR results were scored as positive or negative using techniques and cutoffs that may not have been ...exposure, and would have tended to weaken and obscure any real differences in the ... Voir le document complet
13
Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
... known risk factors for breast cancer: age at menarche (<13, 13–14, or ≥15 years); height (continuous); body mass index category (time-dependent variable according to height at baseline and ... Voir le document complet
18
Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.
... use and other risk factors on the breast cancer incidence ...birth and parity, and family history of breast cancer in first-degree ...index and history of ... Voir le document complet
11
Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort
... recent and less recent physical activity ...inclusion and more than 10 years before inclusion (6–12), and all but two (6, 12) took these two assessments into account ...of breast ... Voir le document complet
11
Several anthropometric measurements and breast cancer risk: results of the E3N cohort study.
... characteristics and breast ...premenopausal and 860 postmenopausal incident invasive breast ...weight, breast, thorax, waist and hip circumferences and calculated body ... Voir le document complet
11
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
... where oral micronized progesterone has been used by large numbers of menopausal women since over two ...BC risk was found in women receiving these treatments ...HRT before enrolment and who ... Voir le document complet
19
Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study.
... between breast cancer and induced abortion but that there is a possible association with spontaneous ...inverted before and after the menopause and this may explain why ... Voir le document complet
12
Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study.
... lower risk of breast cancer (Layde et al, 1989; Parazzini et al, 1993; Den Tonkelaar and de Waard, ...observations and the fact that the relationships observed were not modified by ... Voir le document complet
10
Breast cancer and serum organochlorine residues
... of breast feeding history, and of rural and urban women in the two ...concentration and age, or, for women with breast cancer, tumour size and oestrogen receptor ...DDT ... Voir le document complet
4
en fr Aggressive breast cancer : consequences of chemotherapy-induced menopause in young women with non metastatic breast cancer and prognostic factors of relapse in triple negative breast cancer Les cancers du sein agressifs : conséquences de la ménopause chimio-induite chez les femmes jeunes atteintes d'un cancer du sein non métastatique et facteurs pronostiques de la rechute du cancer du sein triple négatif
... O., and Collaborative Group on Hormonal Factors in Breast ...tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 ... Voir le document complet
177
Re: "Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use".
... BETWEEN BREAST CANCER RISK AND THE CATALASE GENOTYPE, FRUIT AND VEGETABLE CONSUMPTION, AND SUPPLEMENT USE” We read with interest the paper by Ahn et ...on breast ... Voir le document complet
4
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
... Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer Christopher A. Maxwell 1 * ¤a , Javier Benı´tez 2,3 , Laia Go´mez-Baldo´ 1,4 , Ana Osorio 2,3 , Nu´ria Bonifaci ... Voir le document complet
19
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
... different risk association for a later age at first full-term childbirth with risk of HR-negative and HR-positive tumors, whereas the asso- ciations for parity related factors (such as ever having a ... Voir le document complet
13
General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles
... JS and IN for Germany, CJA and AT for the Netherlands, and DGE and HH for ...GPs and a sample of 3293 breast surgeons in each of these four ...reviewed and approved by the ... Voir le document complet
10
Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review
... MEDLINE and PsycINFO were searched from 1995 (the year when studies on the efficacy of tamoxifen as a risk-reducing medication in high-risk women started to get published) to December ...motivators ... Voir le document complet
10
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
... Memorial Cancer Institute, Department of Cancer Epidemiology and Genetics, Brno, Czech Republic; 75 National Centre for Scientific Research ‘Demokritos’, Molecular Diagnostics Laboratory, INRASTES, ... Voir le document complet
15
Sujets connexes